Voyageur Pharmaceuticals (CVE:VM) Shares Up 47.4% – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shot up 47.4% during trading on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. 1,312,210 shares were traded during trading, an increase of 427% from the average session volume of 249,010 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Price Performance

The stock has a fifty day moving average of C$0.07 and a two-hundred day moving average of C$0.06. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The stock has a market capitalization of C$19.53 million, a price-to-earnings ratio of -14.00 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

See Also

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.